Enrique Gallardo Díaz

11PUBLICATIONS
63CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 28, 2026
Prognostic value of PD-L1 in patients with metastatic renal cell carcinoma (mRCC) treated with antiangiogenic first line drugs (PROANG-SOGUG study).

|Oct 16, 2025
Therapeutic Alliances for Optimizing the Management of Patients with Prostate Cancer: SOGUG Multidisciplinary Expert Panel Recommendations.

Aránzazu González-Del-Alba, Claudio Martínez Ballesteros, José Ángel Arranz

|Dec 14, 2024
Characterization of thrombosis risk in ambulatory patients with cancer: results of the observational, prospective, multicenter CARTAGO study.

Javier Trujillo-Santos, Ignacio García-Escobar, Mercedes Salgado

|Jul 27, 2024
Prognostic Implications of Blood Immune-Cell Composition in Metastatic Castration-Resistant Prostate Cancer.

Enrique Perez-Navarro, Vincenza Conteduca, Juan M Funes

|Mar 21, 2024
A Signal-Finding Study of Abemaciclib in Heavily Pretreated Patients with Metastatic Castration-Resistant Prostate Cancer: Results from CYCLONE 1.

Neeraj Agarwal, Daniel Castellano, Teresa Alonso-Gordoa

|Feb 13, 2024
Improvement of thrombosis management in patients with cancer: a practical consensus document of recommendations for cancer-associated thrombosis patients' healthcare in Spain.

Andrés Muñoz Martín, Antonio Javier Trujillo-Santos, Edelmira Martí

Pageof 2

Frequent Collaborators

3 joint publications

Andrés Muñoz Martín

2 joint publications

Aránzazu González-Del-Alba

1 joint publications

Carlos Crespo

1 joint publications

Javier Soto